EUVIMEDEUVIMED entdecken
Crossref

An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy

Youmei Xiao, Xiuman Zhou iD, Xiaoshuang Niu, Xiaoyun Ye, Danhong Chen, Qingyu Dong, Zhuoying He, Xin Yang, Mengfan Wang, Wenxuan Zeng, Ye Su, Feiyu Luo und 2 weitere

Journal of the American Chemical Society · 25.02.2026 · 148 (7) · 7008-7023

DOI: 10.1021/jacs.5c17801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 22.01.2026. Verfasst von Youmei Xiao und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, Guangdong Province, China. Hauptthemen laut MEDLINE: Lysosomes, Immunotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Fundamental Research Funds for the Central Universities, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesImmunotherapyNeoplasmsNanoparticlesHumansAnimalsTransferrinReceptors, TransferrinProteolysisMiceB7-H1 AntigenCell Line, Tumor

Substanzen

TransferrinReceptors, TransferrinB7-H1 Antigen

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, Guangdong Province, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518033, Guangdong Province, China.
  • Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China.

ORCID-Profile: Xiuman Zhou, Yanfeng Gao

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Government

Zitieren

APA

Xiao, Y., Zhou, X., Niu, X., Ye, X., Chen, D., Dong, Q., He, Z., Yang, X., Wang, M., Zeng, W., Su, Y., Luo, F., Liu, J., & Gao, Y. (2026). An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy. Journal of the American Chemical Society, 148(7), 7008-7023. https://doi.org/10.1021/jacs.5c17801

Vancouver

Xiao Y, Zhou X, Niu X, Ye X, Chen D, Dong Q, et al. An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy. Journal of the American Chemical Society. 2026;148(7):7008-7023. doi:10.1021/jacs.5c17801

BibTeX
@article{Xiao2026,
  author = {Xiao, Youmei and Zhou, Xiuman and Niu, Xiaoshuang and Ye, Xiaoyun and Chen, Danhong and Dong, Qingyu and He, Zhuoying and Yang, Xin and Wang, Mengfan and Zeng, Wenxuan and Su, Ye and Luo, Feiyu and Liu, Juan and Gao, Yanfeng},
  title = {An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {7},
  pages = {7008--7023},
  doi = {10.1021/jacs.5c17801}
}
Kostenlos starten →